Clinical evaluation of fenoterol aerosol in asthma.
Fenoterol and isoproterenol metered-dose inhalers were compared in 30 asthmatic patients by a double-blind, parallel-group study. FEV1 and FEF 25-75% values recorded after single doses on days 1, 45 and 90 of a three-month continuous treatment period showed that mean increases over baseline were significantly greater and lasted longer with fenoterol.